Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 301.76M P/E 18.02 EPS this Y 9.10% Ern Qtrly Grth -83.70%
Income 9.73M Forward P/E 15.07 EPS next Y 87.50% 50D Avg Chg -11.00%
Sales 184.32M PEG - EPS past 5Y 15.21% 200D Avg Chg -29.00%
Dividend N/A Price/Book 4.79 EPS next 5Y - 52W High Chg -52.00%
Recommedations 1.50 Quick Ratio 3.85 Shares Outstanding 31.93M 52W Low Chg 1.00%
Insider Own 51.14% ROA 5.32% Shares Float 15.72M Beta 0.45
Inst Own 31.50% ROE 17.30% Shares Shorted/Prior 5.73M/5.83M Price 8.29
Gross Margin 79.38% Profit Margin 5.28% Avg. Volume 363,783 Target Price 19.88
Oper. Margin 4.86% Earnings Date Apr 30 Volume 523,244 Change -3.83%
About Zynex, Inc.

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Zynex, Inc. News
04/26/24 Investing in Zynex (NASDAQ:ZYXI) five years ago would have delivered you a 82% gain
04/18/24 Zynex Sets First Quarter 2024 Earnings Call
04/02/24 3 Industrial Stocks Short Sellers Are Hammering: Cracks in the Foundation?
04/02/24 Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award
03/30/24 With 51% ownership, Zynex, Inc. (NASDAQ:ZYXI) insiders have a lot riding on the company's future
03/03/24 Zynex Full Year 2023 Earnings: Misses Expectations
03/02/24 Zynex, Inc. (NASDAQ:ZYXI) Q4 2023 Earnings Call Transcript
03/01/24 Zynex Price Target Raised by RBC Capital, HC Wainwright Analysts
02/29/24 Zynex Inc. (ZYXI) Q4 Earnings and Revenues Miss Estimates
02/29/24 Zynex Inc (ZYXI) Reports 17% Revenue Growth in FY 2023, Announces New $20 Million Stock ...
02/29/24 Zynex Reports Fourth Quarter and Full Year 2023 Financial Results
02/22/24 Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call
02/20/24 Zynex Introduces New Products
02/08/24 Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023
02/06/24 Zynex Receives FDA Clearance for its Next Generation NMES Device
02/02/24 Zynex Recognized in Top 25 Medical Device Companies for 2024
01/28/24 3 Unloved Growth Stocks Poised for a Major Turnaround
01/08/24 Zynex to Participate at the Needham Annual Growth Conference
12/31/23 Is Zynex, Inc.'s (NASDAQ:ZYXI) Recent Stock Performance Tethered To Its Strong Fundamentals?
12/15/23 Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum
ZYXI Chatroom

User Image Stock_Titan Posted - 1 week ago

$ZYXI Zynex Sets First Quarter 2024 Earnings Call https://www.stocktitan.net/news/ZYXI/zynex-sets-first-quarter-2024-earnings-a60k2039skmt.html

User Image UncleStock Posted - 03/28/24

$ENS $TDY $ZYXI suggested for #batteries - value screen: https://zpr.io/nCzbt

User Image VrtcIl Posted - 1 month ago

Exercise patience and wait for pullbacks in $ZYXI as potential opportunities for entering positions at safer and more advantageous points. Monitoring the chart during these retracements can provide a more strategic and risk-averse entry. Price: 13.39 Float: 19.1M Short Float: 30.4 % 💰 Dollar Volume: 14.4K ℹ️ USA | Medical Distribution

User Image CrayP Posted - 1 month ago

$ZYXI Worst part of call for me seemed that they were still far from any sale process and have also been looking at significant acquisitions themselves... guidance wasn't great but losing the takeover premium that was built-in worse over the near term.

User Image Ninja_Tradez Posted - 1 month ago

📢 $ZYXI - HC Wainwright & Co. Maintains Buy on Zynex, Raises Price Target to $21 https://newsfilter.io/a/51e37af35efa575861c1cabfd8d3a365

User Image Thestocktraderhubzee Posted - 1 month ago

$ZYXI HC Wainwright & Co. Maintains Buy on Zynex, Raises Price Target to $21

User Image epsguid Posted - 02/29/24

$ZYXI reported earnings of $0.04, consensus was $0.17 via @eWhispers #epsmiss http://eps.sh/d/zyxi

User Image DonCorleone77 Posted - 02/29/24

$ZYXI Zynex announces additional $20M share repurchase program The Board of Directors approved an additional $20M share repurchase plan which will commence on March 4, 2024, and terminate on the earlier of March 4, 2025, or when the $20M limit is reached.

User Image DonCorleone77 Posted - 02/29/24

$ZYXI Zynex reports Q4 EPS 4c, consensus 17c Reports Q4 revenue $47.3M, consensus $54.53M. "2023 was a year of continued execution for Zynex, underscored by record revenues and order numbers, and exciting new products and technological innovation," said Thomas Sandgaard, President and CEO of Zynex. "A strong cadence of increasing sales and profitable growth for our pain management division delivered a 43% improvement in orders year-over-year. Our continued profitability and record positive cash flow allowed us to announce an additional $20 million share repurchase plan in the fourth quarter which is almost complete as of today. Our Board of Directors has approved an additional $20 million share repurchase plan which will commence on March 4, 2024, and terminate on the earlier of March 4, 2025, or when the $20 million limit is reached. We have repurchased $65 million of our common stock and reduced our outstanding common shares by over seven million during the last 24 months."

User Image Stock_Titan Posted - 02/29/24

$ZYXI Zynex Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/ZYXI/zynex-reports-fourth-quarter-and-full-year-2023-financial-fe0o82f23u38.html

User Image CrayP Posted - 1 month ago

$ZYXI Writing covered calls here. It's been a great run but given the various litigation and insurance reimbursement risk I don't think anybody's gonna pay much of a premium to current trading levels with regards to the ongoing stragic process. Also gonna be a long slog to get new products into hospitals since they have no sales presence three... it's all prescribing physicians/pain docs with the 500 reps they have.

User Image TickerDD_com Posted - 2 months ago

From 2/16/2024, looking back across 22 Month-Ends for ZYXI, Percentage Change of Average Monthly Price had More Positives (77%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ZYXI #ZYXI #ZYXIStock #TickerDD #ZYXIPrice https://www.youtube.com/watch?v=An5CimPn5_U

User Image UncleStock Posted - 2 months ago

$SMLR $FLGT $IRMD $ZYXI suggested for Medical Equipment and Services - value screen: https://zpr.io/58kdvfpRwWhn

User Image Stock_Titan Posted - 2 months ago

$ZYXI Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call https://www.stocktitan.net/news/ZYXI/zynex-sets-fourth-quarter-and-full-year-2023-earnings-k16wb9e15aj8.html

User Image Stock_Titan Posted - 2 months ago

$ZYXI Zynex Introduces New Products https://www.stocktitan.net/news/ZYXI/zynex-introduces-new-umhtttak02ja.html

User Image ZeroSet Posted - 2 months ago

$ZYXI Overdue for a short squeeze.

User Image LeijaAtx Posted - 2 months ago

$ZYXI I'm buying more

User Image Tommaco Posted - 2 months ago

$ZYXI

User Image Ninja_Tradez Posted - 2 months ago

📢 $ZYXI - Zynex Receives FDA Clearance for its Next Generation NMES Device https://newsfilter.io/a/e4ad879b13a5fe795b8942581f3eb179

User Image Stock_Titan Posted - 2 months ago

$ZYXI Zynex Receives FDA Clearance for its Next Generation NMES Device https://www.stocktitan.net/news/ZYXI/zynex-receives-fda-clearance-for-its-next-generation-nmes-9fqnet13123i.html

User Image UncleStock Posted - 2 months ago

$SMLR $ZYXI $FLGT $IRMD suggested for Medical Equipment and Services - value screen: https://zpr.io/58kdvfpRwWhn

User Image ZbonaNews Posted - 2 months ago

$ZYXI https://zbonanews.com/2024/02/02/zynex-recognized-in-top-25-medical-device-companies-for-2024/

User Image UncleStock Posted - 3 months ago

$ZYXI $ENS $CGNX suggested for #batteries - value screen: https://zpr.io/nCzbt

User Image macroaxis Posted - 3 months ago

$ZYXI - Zynex maximum pain is plunging https://www.macroaxis.com/stock-options/ZYXI/Zynex-Inc?utm_source=dlvr.it&utm_medium=stocktwits

User Image fin_researcher Posted - 3 months ago

$ZYXI anybody heard of it? https://11thestate.com/cases/zynex-investor-case "On March 6, 2023, Zynex announced delay in release of its Q4 and full year financial results and conference call initially scheduled for March 6, 2023. On it, $ZYXI fell 21%, losing $89M+ of shareholder value. Investors may have grounds to suspect Zynex of withholding its financial information, which led to their losses."

User Image tickeron Posted - 3 months ago

$ZYXI enters bullish trend https://srnk.us/go/4971458

User Image StockAutomatePro Posted - 3 months ago

$ZYXI Chart analysis indicates a downward trend for the stock. We alerted the SELL signal at $11.12 and we were able to close this one with profit at $10.11 🎯 See more details at StockAutomate.com

User Image tickeron Posted - 3 months ago

$ZYXI enters bullish trend https://srnk.us/go/4968231

User Image tickeron Posted - 3 months ago

$ZYXI enters bullish trend https://srnk.us/go/4967271

User Image tickeron Posted - 3 months ago

$ZYXI enters bullish trend https://srnk.us/go/4966350

Analyst Ratings
RBC Capital Outperform Mar 1, 24
HC Wainwright & Co. Buy Mar 1, 24
RBC Capital Outperform Oct 16, 23
HC Wainwright & Co. Buy Apr 28, 23
HC Wainwright & Co. Buy Apr 12, 23
Ladenburg Thalmann Buy Mar 28, 23
HC Wainwright & Co. Buy Mar 14, 23
Piper Sandler Overweight Jan 6, 23
Piper Sandler Neutral Oct 28, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sandgaard Thomas PRESIDENT, CEO AND C.. PRESIDENT, CEO AND CHAIRMAN Oct 16 Option 0.20 209,000 41,800 14,604,465 10/17/23
MOORHEAD DANIEL J Chief Financial Offi.. Chief Financial Officer Aug 04 Sell 8.49 20,000 169,800 24,179 08/07/23
Lucsok Anna Chief Operating Offi.. Chief Operating Officer Aug 04 Sell 8.41 12,000 100,920 17,840 08/07/23
Lucsok Anna Chief Operating Offi.. Chief Operating Officer Dec 13 Sell 13.98 1,103 15,420 13,973 12/13/22
MOORHEAD DANIEL J Chief Financial Offi.. Chief Financial Officer Oct 29 Sell 10.68 38,126 407,186 18,405 11/01/22
MOORHEAD DANIEL J Chief Financial Offi.. Chief Financial Officer Jun 14 Sell 16.2 25,000 405,000 13,483 06/14/21